Editorial: Don’t inject politics into vaccine fight
A version of this editorial first appeared in USA Today. The Pocono Record endorses this opinion.
In recent years, the anti-vaccine movement in the United States has become something of a disease itself, finding willing hosts in both the conspiracy theorists of the right and Big Pharma doubters of the left.
In a CNN poll taken early this month, only about half of Americans said they would try to get a COVID-19 vaccine once one is available, a percentage that seems to have declined in the past five months.
This makes it vital that government officials not do anything to sow doubts about a COVID-19 vaccination that is needed to help the nation return to some sort of normalcy. And the only way to do that is to insist that all vaccines are thoroughly tested in clinical trials to make sure they are both safe and effective.
On this front, there is good news and bad news to report. The good news: This month, the Food and Drug Administration published guidelines requiring vaccine makers to monitor their clinical trial patients for a median duration of at least two months after administering their last dose. These two months are necessary to ensure that people don’t have delayed reactions to the vaccine.
The bad news: Getting to this step took work. The White House reportedly held up the guidelines, trying to finagle some politically motivated announcement before Election Day. And when science ultimately prevailed, President Donald Trump responded with an all-too-common snitfest. In a tweet he called the FDA guidelines a “political hit job.”
The FDA, which has approval authority for new vaccines, deserves credit for sticking up for principle in this case. But it, too, has taken some questionable actions under pressure from the White House.
First the agency authorized (and then revoked) emergency use of the unproven drug hydroxychloroquine to treat COVID-19 patients. Then, in August, it granted emergency authorization for use of convalescent plasma as a treatment even though outside doctors said the evidence from trials was still somewhat ambiguous. It then further undermined its credibility by announcing its decision in political, not medical terms: “Another Achievement in Administration’s Fight Against Pandemic,” it said in a press release.
The FDA will be tested again in coming days as it is under political pressure to approve another type of treatment using so called monoclonal antibodies. Eli Lilly and Regeneron both make such a treatment, and the latter was given to the president himself after he was diagnosed with COVID-19.
It is time to stop politically motivated discussions of vaccines and treatments. It is time to begin a sober and professional discussion of what lies ahead.
Sorting all of this out will require careful, responsible public health messaging. The coronavirus pandemic, which has claimed more than 214,000 American lives and is still going strong, is bad enough. Political grandstanding and anti-vax fearmongering will only make it worse.
The Pocono Record is a member of the USA TODAY Network.
*** This article has been archived for your research. The original version from Pocono Record can be found here ***
